Edition:
United States

Novozymes A/S (NZYMb.CO)

NZYMb.CO on Copenhagen Stock Exchange

291.90DKK
10:12am EDT
Change (% chg)

kr.0.80 (+0.27%)
Prev Close
kr.291.10
Open
kr.291.10
Day's High
kr.292.30
Day's Low
kr.289.70
Volume
310,489
Avg. Vol
511,495
52-wk High
kr.334.60
52-wk Low
kr.220.70

NZYMb.CO

Chart for NZYMb.CO

About

Novozymes A/S is a Denmark-based biotechnology company engaged in the production and sale of industrial enzymes, microorganisms and biopharmaceutical ingredients. The Company operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. It develops and... (more)

Overall

Beta: 1.10
Market Cap(Mil.): kr.73,140.73
Shares Outstanding(Mil.): 251.26
Dividend: 4.00
Yield (%): 1.37

Financials

  NZYMb.CO Industry Sector
P/E (TTM): 28.51 20.91 36.21
EPS (TTM): 10.21 -- --
ROI: 22.08 19.68 11.77
ROE: 28.54 28.60 15.08

BRIEF-Novozymes CFO steps down

* BENNY D. LOFT TO STEP DOWN AS CFO AND EXECUTIVE VICE PRESIDENT Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Jun 15 2017

BRIEF-Novozymes says co, Heinz-Jürgen Bertram mutually decided that he will resign from co's board with effect as of June 8, 2017

* Novozymes - Co, Heinz-Jürgen Bertram have mutually decided that Heinz-Jürgen Bertram will resign from Novozymes' board with effect as of June 8, 2017 Source text for Eikon: Further company coverage: (Bengaluru Newsroom)

Jun 08 2017

REFILE-UPDATE 1-Novozymes shares rise to 9-month high after Q1 earnings

April 26 Danish enzymes maker Novozymes posted slightly better-than-expected revenues for the first quarter on Wednesday and said it would launch a new product in the autumn, sending its shares up more than 5 percent to a nine-month high.

Apr 26 2017

BRIEF-Novozymes Q1 EBIT up at DKK 1.01 billion, in line with expectations

* "GOOD START TO 2017 WITH PROGRESS ON OUR STRATEGIC PRIORITIES."

Apr 26 2017

Denmark's Novo A/S ups Synlab stake to 20 pct before possible IPO

COPENHAGEN, April 12 Danish life science investor Novo A/S said on Wednesday it was raising its stake in Synlab to about 20 percent through a 250 million euro ($265 million) subscription to new shares, ahead of a potential listing of Europe's second largest lab operator.

Apr 12 2017

BRIEF-Novozymes, Boehringer announce strategic collaboration in probiotics for poultry hatcheries

* Novozymes and Boehringer Ingelheim announce strategic collaboration in probiotics for poultry hatcheries

Mar 30 2017

BRIEF-Dong Energy to build biogas plant for Novo Nordisk, Novozymes residues

* Says will in cooperation with Bigadan build a large-scale biogas plant

Mar 23 2017

BRIEF-Coor Service Management Holding signs agreement with Novozymes in Denmark

* Delivery to Novozymes starts May 1 Source text: http://bit.ly/2mviZql

Mar 23 2017

BRIEF-Novozymes President and CEO buys 27,700 shares at DKK 6,997,574

* President and CEO Peder Holk Nielsen buys 27,700 shares in Novozymes at 6,997,574 Danish crowns ($1 million) Source text for Eikon:

Jan 26 2017

BRIEF-Novozymes initiates stock buyback program

* Will buy back B shares worth up to 2 billion Danish crowns ($288.9 million) in total during remainder of 2017, corresponding to around 8.1 million B shares at current share price

Jan 24 2017

More From Around the Web

Earnings vs. Estimates